Navigation Links
CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
Date:9/11/2007

KIRKLAND, Wash., Sept. 11 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (the "Company") (OTC Bulletin Board: CCYG) has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation of Cleveland, Ohio. The goal of the collaboration is to investigate the presence and regulation of heart receptors involved in stem cell trafficking in normal and diseased human hearts, using CellCyte's proprietary compounds.

CellCyte Genetics is developing stem cell enabling therapeutic products designed to allow more efficient delivery and significantly increased retention of adult stem cells to diseased organs, such as the heart. The goal of this therapy is to increase the number of stem cells delivered to a damaged organ, thereby increasing organ healing and functional restoration. The Company's first product in development, CCG-TH30, is designed to send autologous bone-marrow-derived (adult) stem cells to the heart of patients after a heart attack. In preclinical models, CCG-TH30 has been shown to increase the retention of stem cells up to as much as 80% compared to conventional methods, which achieve only up to about 7%. Importantly, CellCyte's product can be delivered intravenously through the patients' circulatory system without an invasive procedure.

The lead investigators of the project at Cleveland Clinic Foundation are Dr. Wilson Tang M.D. and Dr. Sathyamangla Prasad Ph.D., both accomplished and renowned scientists in the field of cardiac biology. Dr. Tang is also a physician and key opinion leader in cardiac medicine.

The Cleveland Clinic Foundation scientists will analyze heart tissue samples of heart failure patients for the presence of surface receptors that are hypothesized to play an important role in the interaction of stem cells with the heart. These studies are expected to provide valuable novel information that will increase the understanding of cardiac regeneration and will thereby sup
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
2. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
3. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable Cytogenetics at EHA Meeting
6. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
7. Myriad Genetics Presents Tumor Origin Technology at AACR
8. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
9. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
10. Myriad Genetics Presents Azixas Mode of Action at AACR
11. Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...v. 29 FUJIFILM Medical Systems USA...volutionary flat panel DR cassette, at the 2009 Ra...Meeting. Ideal for any clinical environment, FDR ... clinicians with Fujifilm,s trademark image qualit...smart way for users to transition to DR without mo...
(Date:11/29/2009)...v. 29 Stimulated by the ten years ...lm Medical Systems USA announced today, at the Rad...eeting, the formation of its Medical Informatics ...is new group will integrate all functions associat...ates a platform for future growth. ,, Several o...
(Date:11/29/2009)...v. 29 Researchers using functional...activation have found that men and women respond d...ding to a study presented today at the annual meet...RSNA). ,, "Men may direct more attention to sen...ess them in terms of implications for required act...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit M 5623 1VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit M 5623 2VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit M 5623 3Improving schools for disabled students is NJIT researchers mission 59864 1Improving schools for disabled students is NJIT researchers mission 59864 2Improving schools for disabled students is NJIT researchers mission 59864 3GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 1GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 2GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 3
...O, May 20 A post hoc analysis showing,time to sym...hire plc,s,(LSE: SHP, Nasdaq: SHPGY) ulcerative co...ay at Digestive Disease Week (DDW). Study 302 (fur...l A. Kamm, from St Mark,s,Hospital in London, UK),...ission in patients with active, mild to moderate u...
... May 20 GlaxoSmithKline and Synta,Pharmaceuticals...hase II,clinical data for elesclomol (formerly STA...lopment for metastatic melanoma. A retrospective a...atients treated with elesclomol,and paclitaxel who...atistically significant improvement in progression...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 6Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 2Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 3Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 4Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 5Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 6Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 7
(Date:11/28/2009)...swire/ -- Get ready for advanced visualization ... when Siemens introduces syngo. via(1) a...of the Radiological Society of North America (RSNA...e (Booth #825, East Building/Lakeside Center, Hall... new imaging software for multimodality reading of...
(Date:11/28/2009)...o affect circadian rhythm, , , FRID...sts that an internal body clock that goes on the f...ar disorder in children. , The finding results... children with bipolar disorder, which can make pe...ldren without the disorder. They linked variations...
(Date:11/27/2009)... GSI Group Inc. (Pink She...n technology products and semiconductor systems, t...ny,s shareholders has been scheduled for Friday, A...ng will be announced in due course. As previously...ice from Stephen Bershad, a holder of greater than...
(Date:11/27/2009)...m Replikins Ltd. today issued its latest biochemic...ows that the lethality of the virus has dropped fr...urrent outbreak in the spring of 2009 to resting n...e H1N1 infectivity count, however, remains increas...mber 27, 2009 -- Biotech firm Replikins Ltd., whic...
(Date:11/27/2009)...Newswire-FirstCall/ -- The Gymboree Corporation (N...OO, will present at the NASDAQ OMX 23rd Investor P...n London, England, on Wednesday, December 2, 2009,...dcast of The Gymboree Corporation,s presentation o...m, click on "Our Company" at the bottom of the pag...
Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
...king place, experts say , , THURSDAY, Sept...ng to heal psychologically -- as much as it is pos... on the World Trade Center towers on Sept. 11, 200... happened over the past seven years is we,re seein...
... Non-US Healthcare Media, - Global QUEST Study Re...ificantly Improved Survival Outcomes With Vetmedin...e today welcoming new research that,delivers the p...st common type of heart failure live on average 91...
...vices, Inc. (NYSE: ACS ) today announced that it ...nce Program (EPAP), now activated for,residents in...v., The EPAP program, established by the Centers ...surance living in, or,evacuated from, declared fed...
...pular,types of health care coverage are projected ...inder of 2008 and into 2009, according to a nation...are among the results of a survey released today b...ealth,insurers, HMOs and third-party administrator...
...rstCall/ - DiagnoCure Oncology,Laboratories, a sub...ship,of the Colon Cancer Alliance,s (CCA) inaugura...ght Colon Cancer" being held in Philadelphia, PA,o...e at the "Championship Level" to coincide with the...
... Phase 3 Clinical Trial, VALENCIA, Calif., Sept. ...nounced that it will host an analyst day,for the i...m Phase 3 and,other clinical trials of the company... access the live audio broadcast or,the subsequent...
Other Medicine News:Health News:9/11's Psychological Scars Slowly Healing 2Health News:9/11's Psychological Scars Slowly Healing 3Health News:9/11's Psychological Scars Slowly Healing 4Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 2Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 3Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 4Health News:ACS Facilitates Emergency Prescription Assistance Program Now Activated in Southern Louisiana 2Health News:Health Care Cost Increases to Continue at Double Digit Rates, According to Buck Consultants Survey 2Health News:Health Care Cost Increases to Continue at Double Digit Rates, According to Buck Consultants Survey 3Health News:Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test 2Health News:Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test 3Health News:Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test 4Health News:MannKind Corporation to Host Webcast Analyst Day September 16, 2008 2
... easily couple with standard surgical C-arms. Quic...ime consuming delays. Optical coupling can be perf...ng arm provides ultrasound imaging, too. ,Positi...ich comes equipped with three exchangeable mid-sec...
Self-Cath® Plus Soft Cath (soft catheter)
Self-Cath® Plus Straight Tip - Female
Self-Cath Closed System Tapered Tip Coude with Guide Stripe, single units
Medicine Products: